Oral ofloxacin for the treatment of acute bacterial pneumonia: Use of a nontraditional protocol to compare experimental therapy with “usual care” in a multicenter clinical trial☆
References (24)
Clinical overview of the newer 4-quinolone antibacterial agents
- et al.
In vitro properties of the quinolones
Pharmacokinetics of fluoroquinolones
- et al.
Laboratory survey of fluoroquinolone activity
Rev Infect Dis
(1989) - et al.
Pharmacokinetics of ofloxacin after parenteral and oral administration
Antimicrob Agents Chemother
(1987) Pharmacokinetics of ofloxacin: an overview
Am J Med
(1989)- et al.
Penetration of ofloxacin into bronchial secretions
Drugs
(1987) - et al.
The penetration of ofloxacin into lung tissue
J Antimicrob Chemother
(1988) - et al.
The penetration of ofloxacin into bronchial secretions
J Antimicrob Chemother
(1988) - et al.
Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding
Antimicrob Agents Chemother
(1989)
Methods for dilution antimicrobial susceptibility tests for bacteria that grow anaerobically
Performance standard for antimicrobial disk susceptibility tests
Cited by (47)
Oral vs. parenteral antibiotic therapy in adult patients with community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials
2023, Journal of Global Antimicrobial ResistanceQuinolones
2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious DiseasesEfficacy and safety of oral and early-switch therapy for community-acquired pneumonia: A randomized controlled trial
2001, American Journal of MedicineCitation Excerpt :Our study supports the growing evidence that an oral course of antibiotics is safe and effective in patients currently admitted to the hospital who do not have severe pneumonia; it also suggests that these patients could be treated safely as outpatients or admitted for a short stay until a favorable course is observed. In patients with severe pneumonia, our results support the findings of previous retrospective (22), nonrandomized (23,24), or noncontrolled (25–28) studies and studies that had less well-defined inclusion and severity criteria (29–32). Those studies reported that treatment can be switched to oral therapy in patients who do well clinically.
Strategies for early discharge of the hospitalized patient with community-acquired pneumonia
1999, Clinics in Chest Medicine
- ☆
This study was supported by a grant from Ortho Pharmaceutical Corporation, Route 202, Raritan, New Jersey.